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Abstract
Objectives: Ultrasonography (US), computed tomography (CT) and magnetic resonance imaging
(MRI) are the most common radiological procedures for the diagnosis of tumor-like lesions of the
salivary glands. The aim of the present study was to determine whether MRI or CT provide
additional information besides that delivered by US.
Study design/Methods: 109 patients with a tumor-like lesion of the salivary glands underwent
surgery. MRI and CT were arranged in 73 and in 40 patients respectively, whereas all 109 patients
were prospectively diagnosed by US. The results of CT, MRI and US were compared with the
histological outcome. Furthermore, the recent rise in the number of CT and MRI studies was
investigated.
Results: On CT and MRI, there was no rise in the percentage of malignant tumors or advanced
surgical procedures. In respect of the radiological assessment of the lesion (benign/malignant) and
the correct diagnosis, CT, MRI and US were comparable in terms of sensitivity, specificity and
accuracy. No significant difference was found in the Chi-square test (p > 0.05).
Conclusion: The evaluation of the preoperative results of CT, MRI and US revealed no advantage
for CT or MRI; these procedures are only required in specific cases. An update or revision of the
current preoperative diagnostic management is deemed necessary.
Background
Tumor-like lesions of the salivary glands constitute 3% to
6% of all head-and-neck tumors. Besides clinical exami-
nation (palpation), salivary gland tumors – malignant or
benign – are diagnosed by imaging procedures such as
computed tomography (CT), magnetic resonance imag-
ing (MRI) or ultrasonography (US); sialography has
become less popular. Most guidelines of ENT task forces
[2] recommend ultrasound as the initial imaging modal-
ity of choice for the assessment of palpable abnormalities
of the salivary gland. US is able to demonstrate benign
and malignant features of focal lesions and can be used to
guide fine-needle aspiration biopsy or core biopsy to con-
firm their benign or malignant nature (Figure 1). Further-
more, US can be used to establish the need for imaging
procedures (CT or MRI), particularly in those lesions
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showing malignant features on ultrasonography, or large
masses whose extent is difficult to assess with US, particu-
larly if located in the deep lobe [8,14][16] .
CT is also useful for the detection of tumors and the
assessment of tumor extent. However, CT is limited with
regard to the prediction of histopathological characteris-
tics. Although irregular tumor margins or invasion into
adjacent structures on CT suggests malignancy, a benign
tumor may well mimic a malignant lesion on CT.
In the last decade, technical advancements in the CT tech-
nique have extended the value of this procedure for the
detection and characterization of tumors in regions others
than salivary glands. So far, neither MRI nor CT was found
to be superior in the prediction of the histomorphology of
tumors in the salivary glands (Figure 2). Some studies
found that MRI clearly outweighs CT in this regard [3]. A
study published by Konyuncu et al. in 2003 revealed that
CT and MRI provide nearly the same information for pre-
surgical planning and diagnosis [12]. Freling et al. pointed
out that malignant tumors are marked by erosion of sur-
rounding bone, which is better visualized on CT [5][6].
The purpose of this study was to investigate the capability
of different imaging procedures such as US, MRI and CT
of the recent generation to predict the nature (benign/
malignant) and the presumptive diagnosis of palpable
tumors in the salivary glands. The results were compared
with those of histomorphological studies performed after
the surgical procedure. Furthermore, the use of imaging
modalities as a diagnostic tool in salivary gland tumors by
ENT-specialists and general practitioners were investi-
gated.
Materials and methods
Study population
582 patients with palpable tumor of the salivary glands
were referred to our outpatient department between Janu-
ary 2000 and November 2004 for further diagnosing and
treatment. The total number of scans – MRI or CT – per-
formed in 582 patients during the years 2000–2004, prior
to the visit in the outpatient care, has been assessed. In
order to compare the quality of the different scans the
investigations had to fulfil the guidelines and technical
standards of the American College of Roentgenology
(ACR) [1] (see below).
All patients with standard scans were investigated addi-
tionally, prospectively by an ultrasound in our outpatient
department. 109 of these patients who already had under-
gone a CT, a MRI, or both according to the guidelines and
technical standards of the American College of Roentge-
nology (ACR), before their first examination at the ENT-
department were enrolled in this study (in accordance
with the current version of the 1964 Declaration of Hel-
sinki). In 20 patients of these 109 patients (48 female,
44%; 61 male, 56%; mean age 54.9 years) the submandib-
ular gland was affected while in 89 cases the tumor was
located in the parotid gland.
In 67/582 patients, CTs and MRIs did not meet the criteria
of ACR. These patients were not included to the study.
CT and MRI inclusion criteria
The CT and MRI investigations were performed by radiol-
ogists in private practices or by radiology departments of
different hospitals. The investigations had to fulfil the
guidelines and technical standards of the American Col-
lege of Roentgenology (ACR) [1].
The criteria were as follows:
1. The reports of the CT and MRI examination had to pro-
vide information about the technical equipment and the
parameters used to perform the scan.
2. For CT examination, a transverse scan with intravenous
contrast and a slice thickness of 5 mm or less were man-
datory. A soft tissue algorithm was required for the recon-
struction.
3. For the MRI examination, the protocol consisted of a
T1-weighted sequence before and after intravenous con-
trast, as well as a T2-weighted sequence. Although it was
not mandatory, a fat-suppressed T1-weighted sequence
after contrast application was preferred; this was per-
formed in 52 cases (70.3%).
4. The reports of the CT or the MRI examination had to
include a statement about the nature (benign/malignant)
and the presumptive diagnosis of tumor histomorphol-
ogy (e.g., cystadenolymphoma).
5. The field strength of MRI had to be 1.0 or 1.5 Tesla, and
a standard head coil had to be employed to minimize the
influence of technical factors.
The files were scrutinized to determine whether a general
practitioner or an otolaryngologist had ordered the CT/
MRI examination.
Ultrasound
After initial clinical examination, the US examination was
performed prospectively in each of the 109 patients by
two otorhinolaryngologists (consultant and fellow) using
a 10-MHz head (type EUP-L34T; Hitachi Medical Corp.,
Tokyo, Japan; size: 3 × 1.4 cm) of a commonly used ultra-
sound device (type EUB-525RS; Hitachi Medical Corp.,
Tokyo, Japan). If the tumor lesion was too large for theHead & Face Medicine 2007, 3:19 http://www.head-face-med.com/content/3/1/19
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ultrasound head or located deeper in the salivary gland,
an additional US was performed with a 7.5-MHz probe
(model no. 1409692 LH 302 Siemens Medizintechnik
AG, D-90439 Nuernberg, Germany, size 8.5 × 1.2 cm) of
a Sonoline SI 400 (Siemens Medizintechnik AG, D-90439
Nuernberg, Germany). Both otolaryngologists were
blinded to the results of the CT-/MRI-scans or the patients'
history. Final interpretations forecasting diagnosis from
US were made by the two otolaryngologists in consensus.
Surgical treatment
After the clinical diagnosis had been made, all 109
patients underwent surgery. In 18 cases the submandibu-
lar gland was removed. In two patients the tumor of the
Pleomorphic Adenoma of the left parotid gland Figure 1
Pleomorphic Adenoma of the left parotid gland: Ultrasound image axial and Ultrasound image transversal
Ultrasound image axial Ultrasound image transversal
Pleomorphic Adenoma of the left parotid gland Figure 2
Pleomorphic Adenoma of the left parotid gland: MRI axial T1-weighted image, MRI contrast enhanced axial T1-weighted image 
and MRI axial T2-weighted image
MRI contrast enhanced 
axial T1-weighted image MRI axial T2-weighted image MRI axial T1-weighted imageHead & Face Medicine 2007, 3:19 http://www.head-face-med.com/content/3/1/19
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submandibular gland was suspected to be malignant, and
a complete neck dissection was performed.
In 89 cases the patients underwent surgery of the parotid
gland. In 59 patients a superficial (laterofacial) parotidec-
tomy was sufficient to remove the tumor. Two of these
procedures were revision surgeries. Twenty patients
(cases) underwent total parotidectomy and 8 patients, a
radical parotidectomy with removal of the facial nerve.
Three further patients suffered from a so-called dumbbell
tumor of the parotid gland that required combined para-
pharyngeal and parotid surgery.
Data analysis
After US examination, both otorhinolaryngologists in
each case had to give a statement about the malignant or
benign nature of the lesion, and the correct diagnosis of
the tumor entity, e.g., carcinoma, cystadenolymphoma in
consensus. The statements of the observers were com-
pared with the histological diagnosis.
CT/MRI reports also were compared with the histological
diagnosis in terms of the nature of the lesion (malignant/
benign) and the correct diagnosis.
Cases were rated correct when the result of the CT/MRI or
US matched the histological diagnosis. If they failed to
match, they were rated incorrect. Particularly the assess-
ment of the correct diagnosis in malignant tumors proved
to be difficult. If the two readers were unable to make a
statement about the correct diagnosis, the cases were rated
incorrect.
Statistical analysis
The statistics program used was Statistical Product and
Service Solution 12.0 for Windows (SPSS Inc., Chicago,
Illinois, USA). The Chi-square test was used to compare
results between the three diagnostic tools (CT, MRI and
US). The level of significance was set at p < 0.05. Further-
more, specificity (defined as the proportion of true nega-
tives correctly identified by the test indicating how often a
tumor-like lesion is diagnosed correctly), sensitivity
(defined as the proportion of true positives correctly iden-
tified by the test indicating how often a non-tumor-like
lesion is diagnosed correctly) and the accuracy (defined as
the proportion of true negatives and true positives cor-
rectly identified by the test; indicating the agreement
between the preoperative diagnosis and the histological
outcome) were calculated.
Results
CT/MRI prevalence
The total number of scans – MRI or CT – performed in 582
patients during the years 2000–2004 was n = 179. In order
to compare the quality of the different scans the investiga-
tions had to fulfil the guidelines and technical standards
of the ACR
Interestingly, about 64,3% (n = 114) of these scans met
the inclusion criteria of the study according to the ACR
whereas 35,7% (n = 64) of CT-scans fulfiled not the
required standards (Table 1). The annual frequency of
imaging procedures (CT or MRI) rose from 12.5% in 2000
to 26.3% in 2004 (Table 1).
37% of the scans fulfiling the ACR standards (37%) were
arranged by general practitioners and 63% by ENT-spe-
cialists (Table 2). In contrast, about 60% of CT scans not
fulfiling the standards were arranged by general practi-
tioners.
Table 1: Total Percentage of CT/MRI scans from 2000 to 2004
Year Patients CT MRI CT and MRI Percentage of CT/MRI scans
2000 123 20 11 31 25.1%
2001 151 19 11 30 19.8%
2002 101 13 15 28 27.6%
2003 112 28 18 46 41.0%
2004 95 26 18 44 46.2%
Total 582 106 73 179 30.7%
Year Patients CT* MRI* CT* and MRI* Percentage of CT/MRI scans
2000 123 9 11 20 16.2%
2001 151 8 11 19 12.5%
2002 101 6 15 21 20.7%
2003 112 11 18 29 25.9%
2004 95 7 18 25 26.3%
Total 582 41 73 114 19.8%
*fulfiling the standard ACR = American college of RoentgenologyHead & Face Medicine 2007, 3:19 http://www.head-face-med.com/content/3/1/19
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At least 109 of 582 patients with a palpable suspected
lesion of the salivary gland who had undergone CT or
MRI, meeting the inclusion criteria for CT-or MRI-scan,
prior to their first visit to our outpatient department
underwent surgery and were enrolled for the further
study.
Annual distribution of benign and malignant tumors and 
the operations
In order to detect differences in the distribution of benign
and malignant tumors over the years, we analyzed the
average grade of malignancy, based on the results of post-
surgical histopathology of 109 patients. No major differ-
ences were noted between the years of investigation in
respect of the nature of tumors and the operations per-
formed (Table 3). The maximum percentage of malignant
tumors was observed in the year 2000 (30%) while the
minimum percentage was seen in the year 2002 (Table 3).
The majority of the operations were performed in the year
2001 (37%) (Table 3).
Histological results
The histological findings revealed that a benign tumor
had been removed in 79 patients (72.5%) and a malig-
nant tumor in 30 patients (27.5%). Pleomorphic ade-
noma was the most common benign tumor in 30 cases
(27.5%), followed by cystadenolymphoma in 18 patients
(6.1%). Among malignant lesions, adenocarcinoma was
the most common (9 cases; 8.3%), followed by lym-
phoma (5 cases; 4.6%).
Assessment of the tumor entity
Descriptive statistical analysis (specificity, sensitivity,
accuracy) of the lesions revealed that CT and MRI deliv-
ered similar results as did the ultrasound examination
(Table 4). US achieved in our study a sensitivity of 88%, a
specificity of 54% and an accuracy of 79%. MRI investiga-
tions showed a sensitivity of 98%, a specificity of 52% and
an accuracy of 84% The Chi-square test showed no statis-
tically significant difference between CT/MRI and the
ultrasound examination (Table 4). As expected, three
Table 3: Percentage of benign and malignant tumors and performed operations in 109 patients from 2000 to 2004
Tumors Operations
Year Benign Malignant Extirpation of the submandibular gland Superficial parotidectomy Total/radical parotidectomy; Neck dissection
2000 14 (70%) 6 (30%) 4 (20%) 10 (50%) 6 (30%)
2001 14 (74%) 5 (26%) 4 (21%) 8 (42%) 7 (37%)
2002 15 (75%) 5 (25%) 4 (20%) 11 (55%) 5 (25%)
2003 19 (73%) 7 (27%) 3 (12%) 15 (58%) 8 (30%)
2004 17 (71%) 7 (29%) 3 (13%) 15 (66%) 6 (26%)
Total 79 (72%) 30 (28%) 18 (17%) 59 (54%) 32 (29%)
Table 2: Percentage of CT/MRI scans arranged by General practitioners and ENT-specialists
Imaging not according to standard ACR arranged by
Year GP ENT-Sp
2000 5 (12%) 6 (22%)
2001 7 (17%) 4 (15%)
2002 4 (15%) 2 (11%)
2003 10 (27%) 7 (22%)
2004 12 (29%) 7 (30%)
Total 41 (61%) 26 (39%)
Imaging according to standard of ACR arranged by
Year GP ENT-Sp
2000 7 (35%) 13 (65%)
2001 9 (47%) 10 (53%)
2002 9 (43%) 12 (57%)
2003 12 (41%) 17 (59%)
2004 5 (25%) 20 (75%)
Total 42 (37%) 72 (63%)Head & Face Medicine 2007, 3:19 http://www.head-face-med.com/content/3/1/19
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dumbbell tumors were only seen on MRI or CT and could
not be detected on US, even not with the use of a 7.5-MHz
probe.
Assessment of the correct diagnosis
For the diagnosis of tumor-like lesions, CT and US yielded
nearly the same results in respect of the correct diagnosis.
In comparison, MRI proved superior to US (Table 5). The
Chi-square test showed no significant difference between
CT and US or MRI and US.
Dividing the analysis of correct diagnoses into benign and
malignant tumors, it was found that in benign tumors the
correct diagnosis was drawn in many cases by US/MRI and
CT. The ultrasound examination seemed to be slightly
superior to MRI and CT, although the statistical analysis
revealed no significant differences (Table 6). In contrast,
in malignant tumors it was possible to forecast the correct
diagnosis only in a few cases. Here, MRI seemed to be
slightly superior to the ultrasound examination while the
poorest results were seen on CT (Table 7). The analysis of
malignant tumors also revealed no significant difference
between US, CT and MRI (Table 7).
Discussion
In recent years, an increase in the number of CT and MRI
scans has been recorded for first-line diagnosis in patients
with tumor-like lesions of the salivary glands at the outpa-
tient care of an ENT-department (university hospital).
30.7% of the patients with tumor-like lesions in salivary
glands underwent an imaging procedure – MRI or CT –
prior to US and in about 11.0% of the patients CT scans
lack standards like intravenous contrast or a slice thick-
ness of 5 mm or less. Besides data presentation, the
present study has been performed to highlight several
issues explaining this phenomenon. Especially, one issue
addresses the key question, whether MRI, CT and US
devices of the newer generation were more valid to deduct
the correct diagnosis with special focus on the nature of
the tumor lesion (benign/malignant).
According to our study population, the percentage of CT
and MRI scans with standard quality for first-line diagno-
sis in patients with tumor-like lesions of the salivary
glands ranged from about 12% in the years 2000/1 to
26% in the years 2003/4. However, neither spectrum of
operations nor the percentage of malignant tumors in our
study population differed significantly. Within this con-
text, the behaviors of general practitioners and ENT-spe-
cialists to recommend imaging procedures during the first
visit of patients in their offices has been investigated.
Nearly 37% of those scans, who met the criteria of ARS
and nearly 61% of those CT scans that met not the criteria
of ARS were arranged by general practitioners. In contrast,
63% of imaging, who met the criteria of ARS were
arranged by ENT-specialists. We hypothized that both
groups of medical doctors lack information and experi-
ence to choose a correct diagnostic tool. Obviously they
took the conclusion that CT and MRI scans were the supe-
rior tool to detect tumor like lesion in salivary glands.
Table 4: Assessment of the benign or malignant nature of the lesion
Radiological assessment Histology Sensitivity Specificity Accuracy
benign malignant total
Ultrasound*
Benign 71 13 84 88% 54% 79%
Malignant 10 15 25
Total 81 28 109
CT*
Benign 31 3 34 91% 57% 85%
Malignant 3 4 7
Total 34 7 41
Ultrasound and CT
Benign 30 3 33 88% 57% 83%
Malignant 4 4 8
Total 34 7 41
MRI*
Benign 49 11 60 98% 52% 84%
Malignant 1 12 13
Total 50 23 73
Ultrasound and MRI
Benign 43 11 54 86% 52% 75%
Malignant 7 12 19
Total 50 23 73
* Chi-square analysis: MRI versus Ultrasound χ2 = 0.335; p = ns; CT versus Ultrasound χ2 = 0.831; p = nsHead & Face Medicine 2007, 3:19 http://www.head-face-med.com/content/3/1/19
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Thus, in order to examine the diagnostic value of CT and
MRI versus US, our study patients with already performed
imaging underwent an US-analysis. Results of imaging
devices were compared to postoperative histology of the
pathology. To minimize the influence of technical factors
on the outcome of CT and MRI examinations, the inclu-
sion criteria for imaging, as stated in the material and
methods section, had to be fulfiled.
Benign tumors were found in 72% of patients while
malignant tumors were demonstrated in 28%, both in
accordance with the literature. Pleomorphic adenoma was
the most common entity among benign tumors while
adenocarcinoma was most common among malignant
lesions [4].
In assessing a tumor entity-maligne or benigne, US
achieved in our study a sensitivity of 88%, a specificity of
54% and an accuracy of 79%. These results are compara-
ble to those in the literature, which report an accuracy of
82.3% for US [8]. MRI investigations showed a sensitivity
of 98%, a specificity of 52% and an accuracy of 84%.
According to Takashima et al., MRI achieved a sensitivity
of 60%, a specificity of 88% and an accuracy of 81% in the
assessment of tumor malignancy [18]. Although MRI was
slightly superior to US in the present study, no statistical
significant difference was detected between US versus MRI
or CT.
Furthermore, our results ruled out that superficial tumors
of the parotid gland are well assessed by US. MRI provides
here no additional information about the malignancy,
size, and margins of the tumor as discussed in literature
[17]. Very large tumors or those in a far medial or parap-
haryngeal location tend to cause difficulties [10,16]. In
the present study, none of the dumbbell tumors could be
visualized on the ultrasound examination despite the use
of a 7.5-MHz ultrasound probe, which is able to better vis-
ualize deeper portions of the parotid gland than the 10-
MHz probe. However, all dumbbell tumors could be
assessed well on CT, and particularly on MRI [9] .
In the present study, CT and MRI were comparable in
respect of demonstrating benign and malignant entities
(CT: sensitivity 91%, specificity 57%, accuracy 78%; MRI:
sensitivity 98%, specificity 52%, accuracy 84%). Koyuncu
et al. described the similar results, indicating no signifi-
cant differences between MRI and CT according to tumor
location, invasion, and margin characteristics [12]; both
imaging techniques provided the same information for
pre-surgical planning. However, in contrast, other studies
came to the conclusion that MRI is superior to CT [3] or
that MRI and ultrasound, both achieve a more accurate
diagnosis [7][13][15] .
Forecasting the correct diagnosis of tumor-like lesions of
the salivary gland proved to be difficult. Divided into
benign and malignant lesions, the forecast of the correct
diagnosis was particularly weak for malignant tumors. In
benign tumors, US could forecast the correct diagnosis in
45 of 79 cases, MRI in 27 of 50 cases, and CT in 15 of 33
cases. In malignant lesions US could forecast the correct
Table 6: Assessment of the correct diagnosis: Benign tumors (n = 79)
Radiological assessment Histological diagnosis
correct incorrect total
Ultrasound 45 34 79
CT 15 18 33
Ultrasound and CT 17 16 33
MRI 27 23 50
Ultrasound and MRI 25 25 50
* Chi-square analysis: MRI versus Ultrasound χ2 = 0.572; p = ns; CT versus Ultrasound χ2 = 0.651; p = ns
Table 5: Assessment of the correct diagnosis: All tumors (n = 109)
Radiological assessment Histological diagnosis
correct incorrect total
Ultrasound* 49 60 109
CT* 16 25 41
Ultrasound and CT 19 22 41
MRI* 34 39 73
Ultrasound and MRI 31 42 73
* Chi-square analysis: MRI versus Ultrasound χ2 = 0.719; p = ns; CT versus Ultrasound χ2 = 0.449; p = nsPublish with BioMed Central    and   every 
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diagnosis in 4 of 30 cases, MRI in 7 of 23 cases, and CT in
1 of 8 patients. These observations concur with published
data, where in benign tumors the correct diagnosis could
be established by US in 54%, whereas in malignant
tumors, forecasting the diagnosis of salivary gland tumors
is difficult with any imaging technique [8,11].
In summary, the increase in the number of CT and MRI
scans performed in recent years to diagnose a tumor like
lesion in salivary glands can not be explained by arguing
that CT or MRI represents a superior diagnostic tool. None
of the examined imaging procedures MRI, CT or US is
superior to diagnose a tumor in the salivary glands, but all
imaging procedures allow detecting a tumor. None of the
procedures allows a safety forecast for the correct diagno-
sis of a maligne tumor entity.
Conclusion
The authors recommend that the ENT specialists should
decide whether additional imaging gives further informa-
tion besides history and clinical examination. When
imaging is required, US should be firstly taken into con-
sideration, as it provides different advantages: no radia-
tion, low costs, use of fine needle biopsy and mostly the
same information as other imaging procedures.
Only in special cases, such as a tumor in a deep location,
a dumbbell tumor or bone infiltration, a MRI or CT inves-
tigation should be performed. Scans had to fulfil the most
common standards. Updating or revising the current pre-
operative diagnostic management of tumor-like lesions of
the salivary glands is deemed necessary.
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